Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88


SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention.

Lou X, Han X, Jin C, Tian W, Yu W, Ding D, Cheng L, Huang B, Jiang H, Lin B.

OMICS. 2013 Oct;17(10):510-8. doi: 10.1089/omi.2013.0058. Epub 2013 Jul 29.


SOX2 enhances the migration and invasion of ovarian cancer cells via Src kinase.

Wang X, Ji X, Chen J, Yan D, Zhang Z, Wang Q, Xi X, Feng Y.

PLoS One. 2014 Jun 17;9(6):e99594. doi: 10.1371/journal.pone.0099594. eCollection 2014.


Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells.

Yang N, Hui L, Wang Y, Yang H, Jiang X.

Tumour Biol. 2014 Aug;35(8):7965-73. doi: 10.1007/s13277-014-2045-3. Epub 2014 May 16.


Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients.

Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B.

PLoS One. 2012;7(8):e41335. doi: 10.1371/journal.pone.0041335. Epub 2012 Aug 17.


Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.

Yue P, Zhang X, Paladino D, Sengupta B, Ahmad S, Holloway RW, Ingersoll SB, Turkson J.

Oncogene. 2012 May 3;31(18):2309-22. doi: 10.1038/onc.2011.409. Epub 2011 Sep 12.


EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H.

BMC Cancer. 2012 Mar 19;12:91. doi: 10.1186/1471-2407-12-91.


Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.

Zhang P, Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X, Gao H, Sun H, Li Z.

Cell Death Dis. 2014 Jan 9;5:e991. doi: 10.1038/cddis.2013.526.


Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF.

Mol Cell Biochem. 2012 Apr;363(1-2):257-68. doi: 10.1007/s11010-011-1178-6. Epub 2011 Dec 9.


Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.

Law AY, Wong CK.

Exp Cell Res. 2010 Dec 10;316(20):3425-34. doi: 10.1016/j.yexcr.2010.06.026. Epub 2010 Jul 7.


Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.

Lok GT, Chan DW, Liu VW, Hui WW, Leung TH, Yao KM, Ngan HY.

PLoS One. 2011;6(8):e23790. doi: 10.1371/journal.pone.0023790. Epub 2011 Aug 17.


Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.


Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.

Song J, Shih IeM, Chan DW, Zhang Z.

Neoplasia. 2009 Jun;11(6):605-14, 1 p following 614.


Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

Ma L, Lai D, Liu T, Cheng W, Guo L.

Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):593-602. doi: 10.1093/abbs/gmq067. Epub 2010 Aug 12.


Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.

Zhang X, Liu P, Zhang B, Mao H, Shen L, Ma Y.

Int J Mol Med. 2013 Sep;32(3):623-8. doi: 10.3892/ijmm.2013.1431. Epub 2013 Jul 4.


The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.

Yan Y, Liu H, Wen H, Jiang X, Cao X, Zhang G, Liu G.

Mol Cell Biochem. 2013 Jun;378(1-2):1-7. doi: 10.1007/s11010-013-1579-9. Epub 2013 Apr 12.


Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-κB signaling pathway.

Sun Q, Yao X, Ning Y, Zhang W, Zhou G, Dong Y.

Tumour Biol. 2013 Oct;34(5):2995-3002. doi: 10.1007/s13277-013-0864-2. Epub 2013 May 29.


Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N.

J Cell Biochem. 2011 Oct;112(10):2850-64. doi: 10.1002/jcb.23199.


Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells.

Yu ZH, Liu T, Zhao YH, Huang YY, Gao YT.

Tumour Biol. 2014 May;35(5):4637-44. doi: 10.1007/s13277-014-1607-8. Epub 2014 Jan 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk